These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3821846)

  • 1. Branched-chain alpha-keto acids for the diagnosis of maple-syrup-urine disease.
    Parsons H; Fung E; Snyder FF
    N Engl J Med; 1987 Apr; 316(15):951. PubMed ID: 3821846
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship between the branched chain amino acids and their alpha-ketoacids in maple syrup urine disease.
    Snyderman SE; Goldstein F; Sansaricq C; Norton PM
    Pediatr Res; 1984 Sep; 18(9):851-3. PubMed ID: 6483508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of maple-syrup-urine disease for the first four days of life.
    DiGeorge AM; Rezvani I; Garibaldi LR; Schwartz M
    N Engl J Med; 1982 Dec; 307(24):1492-5. PubMed ID: 7144815
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of maple syrup urine disease on resin coated chromatosheets.
    Kovács J
    Acta Biochim Biophys Acad Sci Hung; 1979; 14(3):119-21. PubMed ID: 547666
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantification of branched-chain amino acids in blood spots and plasma by liquid chromatography tandem mass spectrometry for the diagnosis of maple syrup urine disease.
    Sowell J; Pollard L; Wood T
    J Sep Sci; 2011 Mar; 34(6):631-9. PubMed ID: 21328532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification.
    Heldt K; Schwahn B; Marquardt I; Grotzke M; Wendel U
    Mol Genet Metab; 2005 Apr; 84(4):313-6. PubMed ID: 15781191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maple-syrup-urine disease.
    Wendel U; Lombeck I; Bremer HJ
    N Engl J Med; 1983 May; 308(18):1100-1. PubMed ID: 6835327
    [No Abstract]   [Full Text] [Related]  

  • 8. [3 patients with maple syrup urine disease].
    Merinero B; del Valle JA; García MJ; García Miguel MJ; Barrio MI; García Hortelano J; Morales E; González F; García Aparicio J; Sáez Pérez E
    An Esp Pediatr; 1983 Nov; 19(5):393-400. PubMed ID: 6660657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasogastric drip feeding as the only treatment of neonatal maple syrup urine disease.
    Parini R; Sereni LP; Bagozzi DC; Corbetta C; Rabier D; Narcy C; Hubert P; Saudubray JM
    Pediatrics; 1993 Aug; 92(2):280-3. PubMed ID: 8337030
    [No Abstract]   [Full Text] [Related]  

  • 10. Maple syrup urine disease in Thai infants.
    Pangkanon S; Charoensiriwatana W; Sangtawesin V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S41-4. PubMed ID: 19255991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Branched-chain amino acid-free parenteral nutrition in the treatment of acute metabolic decompensation in patients with maple syrup urine disease.
    Berry GT; Heidenreich R; Kaplan P; Levine F; Mazur A; Palmieri MJ; Yudkoff M; Segal S
    N Engl J Med; 1991 Jan; 324(3):175-9. PubMed ID: 1898534
    [No Abstract]   [Full Text] [Related]  

  • 12. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
    Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
    Yang N; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2839-42. PubMed ID: 23290213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between branched-chain amino acids and branched-chain alpha-keto acids in blood in maple syrup urine disease.
    Langenbeck U; Wendel U; Mench-Hoinowski A; Kuschel D; Becker K; Przyrembel H; Bremer HJ
    Clin Chim Acta; 1978 Sep; 88(2):283-91. PubMed ID: 699323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition of the mutation responsible for maple syrup urine disease in Poll Shorthorns and genotyping Poll Shorthorns and Poll Herefords for maple syrup urine disease alleles.
    Dennis JA; Healy PJ
    Res Vet Sci; 1999 Aug; 67(1):1-6. PubMed ID: 10425233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of Maple Syrup Urine Disease in Newborns.
    Harris-Haman P; Brown L; Massey S; Ramamoorthy S
    Nurs Womens Health; 2017; 21(3):196-206. PubMed ID: 28599741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Maple Syrup Urine Disease in a newborn infant].
    Mazur A; Sykut-Cegielska J; Ciebiera M; Trzeciak J; Taybert J; Kowalik A; Ołtarzewski M
    Med Wieku Rozwoj; 2007; 11(1):65-8. PubMed ID: 17965467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent maple syrup urine disease: two case reports.
    Axler O; Holmquist P
    Pediatrics; 2014 Feb; 133(2):e458-60. PubMed ID: 24394677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain alpha-keto acid dehydrogenase complex.
    Tsuruta M; Mitsubuchi H; Mardy S; Miura Y; Hayashida Y; Kinugasa A; Ishitsu T; Matsuda I; Indo Y
    J Hum Genet; 1998; 43(2):91-100. PubMed ID: 9621512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.